J 2017

A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation

BERNATÍK, Ondřej, Tomasz Witold RADASZKIEWICZ, Martin BĚHAL, Zankruti DAVE, Florian WITTE et. al.

Basic information

Original name

A Novel Role for the BMP Antagonist Noggin in Sensitizing Cells to Non-canonical Wnt-5a/Ror2/Disheveled Pathway Activation

Authors

BERNATÍK, Ondřej (203 Czech Republic, belonging to the institution), Tomasz Witold RADASZKIEWICZ (616 Poland, belonging to the institution), Martin BĚHAL (203 Czech Republic, belonging to the institution), Zankruti DAVE (356 India, belonging to the institution), Florian WITTE (276 Germany), Annika MAHL (276 Germany), Nicole ČERNOHORSKÁ (203 Czech Republic, belonging to the institution), Pavel KREJČÍ (203 Czech Republic, belonging to the institution), Sigmar STRICKER (276 Germany) and Vítězslav BRYJA (203 Czech Republic, guarantor, belonging to the institution)

Edition

Frontiers in Cell and Developmental Biology, Lausanne, Frontiers Media S.A. 2017, 2296-634X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10601 Cell biology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14310/17:00094783

Organization unit

Faculty of Science

UT WoS

000455238900047

Keywords in English

noggin; Wnt5a; non-canonical Wnt pathways; BMP signaling; brachydactyly; Ror2

Tags

Tags

International impact, Reviewed
Změněno: 23/4/2020 16:08, Mgr. Marie Šípková, DiS.

Abstract

V originále

Mammalian limb development is driven by the integrative input from several signaling pathways; a failure to receive or a misinterpretation of these signals results in skeletal defects. The brachydactylies, a group of overlapping inherited human hand malformation syndromes, are mainly caused by mutations in BMP signaling pathway components. Two closely related forms, Brachydactyly type B2 (BDB2) and BDB1 are caused by mutations in the BMP antagonist Noggin (NOG) and the atypical receptor tyrosine kinase ROR2 that acts as a receptor in the non-canonical Wnt pathway. Genetic analysis of Nog and Ror2 functional interaction via crossing Noggin and Ror2 mutant mice revealed a widening of skeletal elements in compound but not in any of the single mutants, thus indicating genetic interaction. Since ROR2 is a non-canonical Wnt co-receptor specific for Wnt-5a we speculated that this phenotype might be a result of deregulated Wnt-5a signaling activation, which is known to be essential for limb skeletal elements growth and patterning. We show that Noggin potentiates activation of the Wnt-5a-Ror2-Disheveled (Dvl) pathway in mouse embryonic fibroblast (MEF) cells in a Ror2-dependent fashion. Rat chondrosarcoma chondrocytes (RCS), however, are not able to respond to Noggin in this fashion unless growth arrest is induced by FGF2. In summary, our data demonstrate genetic interaction between Noggin and Ror2 and show that Noggin can sensitize cells to Wnt-5a/Ror2-mediated non-canonical Wnt signaling, a feature that in cartilage may depend on the presence of active FGF signaling. These findings indicate an unappreciated function of Noggin that will help to understand BMP and Wnt/PCP signaling pathway interactions.

Links

GA15-21789S, research and development project
Name: Dishevelled - identifikace základních koordinát
Investor: Czech Science Foundation
GA17-09525S, research and development project
Name: Neobvyklé signální dráhy lidských receptorových tyrozinových kináz
Investor: Czech Science Foundation
GA17-16680S, research and development project
Name: Nové postupy pro určení aktivity dráhy planární buněčné polarity (PCP)
Investor: Czech Science Foundation
LH15231, research and development project
Name: Nové mechanismy vzniku fatálních kostních ciliopatií u člověka
Investor: Ministry of Education, Youth and Sports of the CR
NV15-33232A, research and development project
Name: Identifikace nových možností léčby achondroplásie prostřednictvím analýzy interakce FGFR3 a adaptérového proteinu Frs2
NV15-34405A, research and development project
Name: Identifikace nových možností léčby chronické myeloidní leukémie pomocí systematické analýzy interaktomu proteinu BCR-ABL